{"id":224576,"date":"2025-10-14T18:07:13","date_gmt":"2025-10-14T18:07:13","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/224576\/"},"modified":"2025-10-14T18:07:13","modified_gmt":"2025-10-14T18:07:13","slug":"counterpart-health-expands-proven-flywheel-for-hedis-excellence-to-third-party-partners","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/224576\/","title":{"rendered":"Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners"},"content":{"rendered":"<p>&#13;<br \/>\n    &#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n&#13;<\/p>\n<p>Counterpart Health (CLOV) said its AI-driven HEDIS flywheel again powered Clover Health Medicare Advantage plans to top-tier results and made the platform available to third-party partners on Oct 14, 2025. Clover was the #1 performing PPO for HEDIS clinical quality measures among plans over 2,000 members and the only PPO in the Top 10. The flywheel combines point-of-care Counterpart Assistant prompts, real-time ingestion from 100+ data sources, NLP\/LLM abstraction, and AI-augmented documentation closure to raise quality and reduce administrative burden.<\/p>\n<p>Counterpart cites improved benchmark rates for screenings and diabetic eye exams and plans to scale the platform to more partners.<\/p>\n<p>Counterpart Health (CLOV) ha dichiarato che il suo volano HEDIS guidato dall&#8217;IA ha nuovamente fornito risultati di alto livello alle assicurazioni Clover Health Medicare Advantage e ha reso la piattaforma disponibile a partner terzi il 14 ottobre 2025. Clover \u00e8 stato il PPO pi\u00f9 performante per le misure di qualit\u00e0 clinica HEDIS tra i piani con oltre 2.000 membri e l&#8217;unico PPO tra i Top 10. Il volano combina prompt di Counterpart Assistant a punto di cura, l&#8217;ingestione in tempo reale da pi\u00f9 di 100 fonti di dati, astrazione NLP\/LLM e chiusura della documentazione potenziata dall&#8217;IA per aumentare la qualit\u00e0 e ridurre l&#8217;onere amministrativo.<\/p>\n<p>Counterpart cita tassi di riferimento migliorati per gli screening e per gli esami oculistici diabetici e prevede di ampliare la piattaforma a pi\u00f9 partner.<\/p>\n<p>Counterpart Health (CLOV) dijo que su volante HEDIS impulsado por IA volvi\u00f3 a impulsar los planes Clover Health Medicare Advantage hacia resultados de primer nivel y puso la plataforma a disposici\u00f3n de socios externos el 14 de octubre de 2025. Clover fue el PPO con mejor rendimiento en las medidas de calidad cl\u00ednica de HEDIS entre planes con m\u00e1s de 2.000 miembros y el \u00fanico PPO en el Top 10. El volante gira combina prompts de Counterpart Assistant en el punto de atenci\u00f3n, ingesta en tiempo real de m\u00e1s de 100 fuentes de datos, abstracci\u00f3n NLP\/LLM y cierre de documentaci\u00f3n potenciado por IA para aumentar la calidad y reducir la carga administrativa.<\/p>\n<p>Counterpart cita tasas de referencia mejoradas para cribados y ex\u00e1menes oculares diab\u00e9ticos y planea escalar la plataforma a m\u00e1s socios.<\/p>\n<p>Counterpart Health (CLOV)\uc758 AI \uc8fc\ub3c4 HEDIS \ud50c\ub77c\uc774\ud720\uc774 \ub2e4\uc2dc Clover Health Medicare Advantage \uacc4\ud68d\uc744 \ucd5c\uc0c1\uc704 \uacb0\uacfc\ub85c \uc774\ub04c\uc5c8\uace0 2025\ub144 10\uc6d4 14\uc77c \uc81c3\uc790 \ud30c\ud2b8\ub108\uc5d0\uac8c \ud50c\ub7ab\ud3fc\uc744 \uc81c\uacf5\ud588\ub2e4\uace0 \ub9d0\ud588\ub2e4. Clover\ub294 HEDIS \uc784\uc0c1\uc758 \uc9c8 \uc9c0\ud45c\uc5d0\uc11c 2,000\uba85 \uc774\uc0c1\uc758 \uacc4\ud68d \uc911\uc5d0\uc11c \ucd5c\uace0\uc758 PPO\uc600\uace0 \uc0c1\uc704 10\uac1c \uc911 \uc720\uc77c\ud55c PPO\uc600\ub2e4. \uc774 \ud50c\ub77c\uc774\ud720\uc740 \ud604\uc7a5 \uc989\uc2dc Counterpart Assistant \ud504\ub86c\ud504\ud2b8, 100\uac1c \uc774\uc0c1\uc758 \ub370\uc774\ud130 \uc18c\uc2a4\uc5d0\uc11c\uc758 \uc2e4\uc2dc\uac04 \uc218\uc9d1, NLP\/LLM \ucd94\uc0c1\ud654, \uadf8\ub9ac\uace0 AI\uac00 \ubcf4\uac15\ud55c \ubb38\uc11c \ub9c8\uac10\uc744 \uacb0\ud569\ud558\uc5ec \ud488\uc9c8\uc744 \ub192\uc774\uace0 \ud589\uc815 \ubd80\ub2f4\uc744 \uc904\uc778\ub2e4.<\/p>\n<p>Counterpart\ub294 \uac80\uc0ac \ubc0f \ub2f9\ub1e8\ubcd1\uc131 \ub9dd\ub9c9\uac80\uc0ac\uc5d0 \ub300\ud55c \ubca4\uce58\ub9c8\ud06c \uac1c\uc120\ub960\uc744 \uc778\uc6a9\ud558\uace0 \ub354 \ub9ce\uc740 \ud30c\ud2b8\ub108\uc5d0\uac8c \ud50c\ub7ab\ud3fc\uc744 \ud655\uc7a5\ud560 \uacc4\ud68d\uc774\ub77c\uace0 \ubc1d\ud614\ub2e4.<\/p>\n<p>Counterpart Health (CLOV) a d\u00e9clar\u00e9 que son volant HEDIS pilot\u00e9 par IA a \u00e0 nouveau donn\u00e9 des r\u00e9sultats de premier ordre pour les plans Clover Health Medicare Advantage et a rendu la plateforme disponible \u00e0 des partenaires tiers le 14 octobre 2025. Clover \u00e9tait le PPO n\u00b01 en performance pour les mesures de qualit\u00e9 clinique HEDIS parmi les plans de plus de 2 000 membres et le seul PPO dans le Top 10. Le volant combine des invites Counterpart Assistant au point de care, une ingestion en temps r\u00e9el de plus de 100 sources de donn\u00e9es, une abstraction NLP\/LLM et une cl\u00f4ture de documentation augment\u00e9e par l&#8217;IA pour am\u00e9liorer la qualit\u00e9 et r\u00e9duire la charge administrative.<\/p>\n<p>Counterpart cite des taux de r\u00e9f\u00e9rence am\u00e9lior\u00e9s pour les d\u00e9pistages et les examens oculaires diab\u00e9tiques et pr\u00e9voit d&#8217;\u00e9tendre la plateforme \u00e0 davantage de partenaires.<\/p>\n<p>Counterpart Health (CLOV) sagte, dass sein KI-gesteuerter HEDIS-Impulsfasen erneut Clover Health Medicare Advantage-Pl\u00e4ne zu Ergebnissen der Spitzenklasse verholfen hat und die Plattform am 14. Oktober 2025 auch Drittpartnern zur Verf\u00fcgung gestellt wurde. Clover war der #1-Performing PPO f\u00fcr HEDIS-Klinikqualit\u00e4tsma\u00dfe unter Pl\u00e4nen mit mehr als 2.000 Mitgliedern und der einzige PPO in den Top 10. Der Impuls fasst Point-of-Care Counterpart Assistant-Eingaben, Echtzeit-Ingestion aus 100+ Datenquellen, NLP\/LLM-Abstraktion und AI-unterst\u00fctzte Dokumentationsabschl\u00fcsse zusammen, um die Qualit\u00e4t zu erh\u00f6hen und die administrative Belastung zu reduzieren.<\/p>\n<p>Counterpart nennt verbesserte Benchmark-Raten f\u00fcr Screenings und diabetische Augenuntersuchungen und plant, die Plattform auf weitere Partner auszuweiten.<\/p>\n<p>Counterpart Health (CLOV) \u0642\u0627\u0644\u062a \u0625\u0646 \u0639\u062c\u0644\u0629 HEDIS \u0627\u0644\u0645\u062f\u0641\u0648\u0639\u0629 \u0628\u0627\u0644\u0630\u0643\u0627\u0621 \u0627\u0644\u0627\u0635\u0637\u0646\u0627\u0639\u064a \u0644\u062f\u064a\u0647\u0627 \u062f\u0641\u0639\u062a \u0645\u0631\u0629 \u0623\u062e\u0631\u0649 \u062e\u0637\u0637 Clover Health Medicare Advantage \u0646\u062d\u0648 \u0646\u062a\u0627\u0626\u062c \u0645\u0646 \u0627\u0644\u0637\u0631\u0627\u0632 \u0627\u0644\u0623\u0648\u0644 \u0648\u062c\u0639\u0644\u062a \u0627\u0644\u0645\u0646\u0635\u0629 \u0645\u062a\u0627\u062d\u0629 \u0644\u0634\u0631\u0643\u0627\u0621 \u0627\u0644\u0637\u0631\u0641 \u0627\u0644\u062b\u0627\u0644\u062b \u0641\u064a 14 \u0623\u0643\u062a\u0648\u0628\u0631 2025. \u0643\u0627\u0646 Clover \u0647\u0648 PPO \u0627\u0644\u0623\u0643\u062b\u0631 \u0623\u062f\u0627\u0621\u064b \u0641\u064a \u0645\u0642\u0627\u064a\u064a\u0633 \u062c\u0648\u062f\u0629 HEDIS \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0628\u064a\u0646 \u0627\u0644\u062e\u0637\u0637 \u0627\u0644\u062a\u064a \u062a\u0636\u0645 \u0623\u0643\u062b\u0631 \u0645\u0646 2000 \u0639\u0636\u0648 \u0648\u0643\u0627\u0646 \u0627\u0644\u0648\u062d\u064a\u062f PPO \u0641\u064a \u0627\u0644\u0639\u0634\u0631\u0629 \u0627\u0644\u0623\u0648\u0627\u0626\u0644. \u062a\u062c\u0645\u0639 \u0627\u0644\u0639\u062c\u0644\u0629 \u0628\u064a\u0646 \u0645\u0648\u062c\u0647\u0627\u062a Counterpart Assistant \u0641\u064a \u0646\u0642\u0637\u0629 \u0627\u0644\u0631\u0639\u0627\u064a\u0629\u060c \u0648\u0627\u0628\u062a\u0644\u0627\u0639 \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0641\u064a \u0627\u0644\u0648\u0642\u062a \u0627\u0644\u0641\u0639\u0644\u064a \u0645\u0646 100+ \u0645\u0635\u062f\u0631 \u0628\u064a\u0627\u0646\u0627\u062a\u060c \u0648\u0627\u0644\u062a\u062c\u0631\u064a\u062f NLP\/LLM\u060c \u0648\u0625\u063a\u0644\u0627\u0642 \u0627\u0644\u062a\u0648\u062b\u064a\u0642 \u0627\u0644\u0645\u0639\u0632\u0632 \u0628\u0627\u0644\u0630\u0643\u0627\u0621 \u0627\u0644\u0627\u0635\u0637\u0646\u0627\u0639\u064a \u0644\u0631\u0641\u0639 \u0627\u0644\u062c\u0648\u062f\u0629 \u0648\u062a\u0642\u0644\u064a\u0644 \u0627\u0644\u0639\u0628\u0621 \u0627\u0644\u0625\u062f\u0627\u0631\u064a.<\/p>\n<p>\u062a\u0634\u064a\u0631 Counterpart \u0625\u0644\u0649 \u0645\u0639\u062f\u0644\u0627\u062a \u0645\u0639\u064a\u0627\u0631\u064a\u0629 \u0645\u062d\u0633\u0646\u0629 \u0644\u0644\u0641\u062d\u0648\u0635\u0627\u062a \u0648\u0627\u0644\u0641\u062d\u0648\u0635\u0627\u062a \u0627\u0644\u0639\u064a\u0646\u064a\u0629 \u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0633\u0643\u0631\u064a \u0648\u062a\u062e\u0637\u0637 \u0644\u062a\u0648\u0633\u064a\u0639 \u0627\u0644\u0645\u0646\u0635\u0629 \u0625\u0644\u0649 \u0645\u0632\u064a\u062f \u0645\u0646 \u0627\u0644\u0634\u0631\u0643\u0627\u0621.<\/p>\n<p>Counterpart Health (CLOV)\u8868\u793a\u5176\u7531AI\u9a71\u52a8\u7684HEDIS\u98de\u8f6e\u518d\u6b21\u4e3aClover Health Medicare Advantage\u8ba1\u5212\u5e26\u6765\u9876\u7ea7\u7ed3\u679c\uff0c\u5e76\u4e8e2025\u5e7410\u670814\u65e5\u5411\u7b2c\u4e09\u65b9\u5408\u4f5c\u4f19\u4f34\u5f00\u653e\u5e73\u53f0\u3002 Clover\u662f\u5728\u6210\u5458\u8d85\u8fc72000\u7684\u8ba1\u5212\u4e2d\u8fbe\u5230HEDIS\u4e34\u5e8a\u8d28\u91cf\u6307\u6807\u7684PPO\u4e2d\u8868\u73b0\u6700\u597d\u7684\u4e4b\u4e00\uff0c\u4e5f\u662f\u524d\u5341\u540d\u4e2d\u552f\u4e00\u7684PPO\u3002\u8be5\u98de\u8f6e\u7ed3\u5408\u73b0\u573a\u70b9\u5bf9\u70b9\u7684Counterpart Assistant\u63d0\u793a\u3001\u6765\u81ea100+\u6570\u636e\u6e90\u7684\u5b9e\u65f6\u6444\u53d6\u3001NLP\/LLM\u62bd\u8c61\uff0c\u4ee5\u53caAI\u589e\u5f3a\u7684\u6587\u6863\u5b8c\u6210\uff0c\u4ee5\u63d0\u9ad8\u8d28\u91cf\u5e76\u51cf\u5c11\u884c\u653f\u8d1f\u62c5\u3002<\/p>\n<p>Counterpart\u63d0\u5230\u7b5b\u67e5\u548c\u7cd6\u5c3f\u75c5\u6027\u773c\u79d1\u68c0\u67e5\u7684\u57fa\u51c6\u7387\u6709\u6240\u6539\u5584\uff0c\u8ba1\u5212\u5c06\u8be5\u5e73\u53f0\u6269\u5c55\u5230\u66f4\u591a\u5408\u4f5c\u4f19\u4f34\u3002<\/p>\n<p>Positive<\/p>\n<p>          &#13;<br \/>\n            &#13;<br \/>\n                    Clover ranked #1 PPO for HEDIS measures among plans &gt;2,000 members&#13;<br \/>\n            &#13;<br \/>\n                    Platform now offered to third-party partners, expanding addressable market&#13;<br \/>\n            &#13;<br \/>\n                    Aggregates clinical data from 100+ sources for unified patient views&#13;<br \/>\n            &#13;<\/p>\n<p>      &#13;<\/p>\n<p>&#13;<br \/>\n          Insights  &#13;\n        <\/p>\n<p>&#13;<br \/>\n    &#13;<\/p>\n<p class=\"tldr\">Counterpart opens its AI HEDIS platform to third parties, scaling a proven quality-improvement flywheel.<\/p>\n<p>Counterpart Health operationalizes an AI-driven flywheel that combines point-of-care assistance, broad data ingestion, NLP\/LLM abstraction, and AI-augmented documentation to close HEDIS clinical gaps. The company reports this stack again powered Clover Health to be the #1 performing PPO for HEDIS measures among plans over 2,000 members, and it is now offering the same platform to third-party partners as of October 14, 2025.<\/p>\n<p>The value proposition rests on three linked capabilities: surfacing actionable gaps at the visit, capturing real\u2011time data from 100+ sources to build a unified patient view, and using AI to reduce abstraction and documentation burden. The biggest dependencies are partner data access and operational adoption by non-employed clinicians; without reliable data feeds or provider workflow integration, the flywheel cannot close gaps at scale.<\/p>\n<p>Watch for three concrete items over the next 6\u201318 months: partner onboarding cadence and any named third\u2011party contracts, measured lift in HEDIS performance among external partners versus baseline, and evidence of data integrations from the claimed &#8220;100 data sources.&#8221; These milestones will show whether the platform\u2019s internal success replicates externally and when scale effects might appear.<\/p>\n<p>          &#13;<br \/>\n        &#13;<\/p>\n<p>&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n    &#13;<br \/>\n    &#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n      10\/14\/2025 &#8211; 08:30 AM&#13;<br \/>\n    &#13;<br \/>\n&#13;<\/p>\n<p>Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans<\/p>\n<p>SAN FRANCISCO, Oct.  14, 2025  (GLOBE NEWSWIRE) &#8212; Counterpart Health,\u202fInc. (\u201cCounterpart\u201d), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq:\u202f<a href=\"https:\/\/www.stocktitan.net\/overview\/CLOV\" title=\"View CLOV stock overview\" class=\"symbol-link\" rel=\"nofollow noopener\" target=\"_blank\">CLOV<\/a>) (\u201cClover,\u201d \u201cClover\u202fHealth\u201d or the \u201cCompany\u201d) and a leading AI-powered value-based care enablement company, today announced that its technology platform has once again powered top-tier HEDIS results for Clover Health Medicare Advantage plans through its AI-driven flywheel. The company is now making this unparalleled HEDIS platform available to third-party partners for the first time.<\/p>\n<p>As with last year, Counterpart has enabled Clover Health to be the #1 performing PPO plan in the country for HEDIS clinical quality measures for plans over 2,000 members. Clover is again the only PPO amongst the Top 10 plans, demonstrating our AI platform\u2019s unique ability to drive both member outcomes and plan performance across a wide network of non-employed physicians, without capitation.<\/p>\n<p>Counterpart Health\u2019s flywheel for HEDIS excellence includes:<\/p>\n<p>    CA-powered visits with clinical care gap closure: at the point of care, Counterpart Assistant (CA) surfaces actionable HEDIS clinical gaps for providers to close, whether by validating existing clinical evidence or ordering needed tests or referrals.Data ingestion: each CA visit triggers real-time clinical data collection from across the healthcare landscape, aggregating from more than 100 data sources to build a unified patient view.AI-powered HEDIS abstraction: Counterpart applies natural language processing (NLP) and large language model (LLM) technologies to identify suspect hits and exclusions for care coordination staff to review.HEDIS documentation gap closure: AI-augmented abstraction tooling closes documentation gaps across measures, allowing PCPs to focus on preventive care and clinical action rather than administrative tasks.    <\/p>\n<p>This flywheel consistently powers superior results for Clover\u2019s Medicare Advantage population. From a patient outcomes perspective, those who see a CA-powered provider are more likely to meet quality benchmarks on a range of measures, including measures focused on colorectal cancer screening, breast cancer screening, and diabetic eye exams, as demonstrated in a previously published <a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=8F75m8sexNVvKROkk0fWK29APHwIZbvTwHIdw0_ErvE7MRF2Z2OBq-eyVRfbrf4ADoAXTCBDc4chtb33touP6zPV3XGR-dsyLcVt8J4SXN58tPSbUd-47qEdw3PoO4bxoMqVvDAJw8FmIwnJq8jtk2UX68Pvx0xmSZO1stMwTaU=\" target=\"_blank\">whitepaper<\/a>.<\/p>\n<p>\u201cThis recognition for the second year running reinforces what we know: our technology doesn\u2019t just reduce administrative burden, it directly improves quality and outcomes,\u201d said Conrad Wai, CEO of Counterpart Health. \u201cBy opening our HEDIS excellence flywheel to third-party partners, we\u2019re enabling more organizations to benefit from the same proven processes that powered Clover\u2019s industry-leading results.\u201d<\/p>\n<p>As Counterpart Health continues to expand its platform, the company is committed to scaling this model across more partners, driving better data, smarter AI, and higher-quality outcomes for value-based care at scale.<\/p>\n<p>About Counterpart Health<br \/><a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=8hPZGreACJRj6JO-ZD0hrjd0so4IWbCzBG2MeeDaZET3NES3w_JxvuIv3dqLHMloPdK5Hxm1F-46-ltYOM0J8qNvwpriyTuavKxCUdz_6zmwYIq_FRCdvPnrPjKzEGqLEfixEgPWpn8VU07k111V1HziBDtBnIUwrEFT_4kRCUnSkJDr_kkl8nk3ruxiqmokdMtLHQqZxNTs0m-nLKiCDS9lxL2Mpy62xu3lsaJzMqSTeX4j7vfdbmaZj7jnuGkZitOdyvEpxok0a9SCil5Xmw==\" target=\"_blank\">Counterpart Health<\/a>, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health\u2019s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health\u2019s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology\u2019s impact on <a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=B6D4wL_kTAHj4DGeuCHiM3u0zW44OvPMe0dIIBNvHlT-UFsiy1cNxuhfV2OI2jDMaYNEiAV8ElGeHM9dROOVSlJHhSrj5DQQDbW-YdzKA7AfveKZEiSw8n3LkYzTDsvCpXSDf0ZK7Pzur2QycxsbWFHPeWqjrXHmItzzLAjozL2T1pmQX6dx11edIfzSKwaen1jtXwokxa9BGetL1fLVa0rQjul9xKAPYeMi_eM_EcdPrkiF0d2izPXXGaCTR1XhlTUZaPSJ8AAaGTOuFgqMTLAr7omJRMIYMZXr3HpnHQusYQUsLNX5DS1GiECEHJO-Fq84q3KwNJrNIPV8VcmCgAgr_kW5MycVZzs73NLiOgdCU9vHNCfyaKKJ3Pmo3pRaCUYU8lANtLQwB4WYaZqFLx9owBX5JUMUDtaCwJb_P0cg5tVJzfWrJCsjdz1AFYnqtuqYtDg7E1bLeEq7KemjAoKNGWMZld9Bc25lJpGsh8o=\" target=\"_blank\">Diabetes<\/a>, <a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yu-6xKxzQfiSQvdRzYU_3EbQnjbAP3qls9wr96diBiYdaQ2UnPpFbg8pc4vcrUF2SR0rd_VD4BugPC2R0_yD88a_pW9lYBG-ZaOi2s0s4aSM2QYK8rpr28tunsnO0hZPr7eKMWAUTY_eU4U1PqvYQ6AXUtdG4omtROLBGBMGMH5apZb6ZO-r1Kj0hdUuOSFzWVoMlOmN1R-KZov8WbZGT3dmxOTB1trX73nMGfSqJNoqtJ26WZm8wJmJwWzydDDxak1hnyRZSog0nuZTs779zZxQmOPc_YOwQTuhiaMYmd9-sDPll4vuB-694wJiDGNz0igTXO6s2Hefz1s_A43kpIyDF3ZuI_KUDUmPOWtgKPUXJM00jE6slhBmB9tX9DKmzy5ee-Dbk0We0llN28WfxLfLPMnQO0daCmuJPF5Ppz9fQvxppaYYb3neyenhx1nF\" target=\"_blank\">Chronic Kidney Disease<\/a>, <a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=fh2GLxEBcY_SPdc_OIKP5tCsVnVTzZB3Fo8qtSJln0dTXv6NkzurZDh5wAgXqno4iOFnjMN96XAa7qClppzs__LSyDNGoFuKDIhWzUsuZWyBxmLFQ6HJW--60T4jtmGSKT_KmivX1rvhbENtqC15L-1KMMB_Mk9jhv2Qn7uL0cUAhFAfAUV3LsZYtLvhypMM6jgelkjoAnp-EOxrjhEEcAyk03RIhnDMltYMwgd0756ycbS-35uth4ys0oLXLzEmJp4qeXzkBFYG1WPaCx56Yby_t5Mw3qLICrEeWPaTEf8Z06YDygB5cOE11oHTGNxEmBLLHmTFKv8reDqZp91B4g7SV0zBVTQtEFGe2NdisyU=\" target=\"_blank\">Congestive Heart Failure<\/a>, and <a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yu-6xKxzQfiSQvdRzYU_3EtqQpCHQwWdW6jMT5iaE5yAF5lLV2Y9g9WlFSenBhmPADvJWbK6l1eOhxJb-WkZFmWjPVOSDjIFMgg3xPFlmoYtm2aXNlUXeQ1VrQW8knLTBARcYXQGlKN7Xm-dGgY0AIgo332hdq_Pkm5dfomH9A6TGObyjoisEJswiiKrzij2\" target=\"_blank\">Chronic Obstructive Pulmonary Disease<\/a> management, and <a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=jesSVumf-sKRDkW5Jy__gui4zrjww6UAbRn2fbHhv7HyxkWTt6TRDK1Wlfdl_tiNGrkhiQ_0G1idkKWE5wSKvBRJiVbGXoxtyqFJeOudDnNbpPn58IYFJCylDstO4SCVagj_6EiN_pHSLaVPwEaF6lFl1WtyZKnD3NDASJ5PpDR5i3YPzcNUJ3qdPMTO_O32V8l3xJeapwovQEaQjxxE7NAXIpeKvTz3FHfle5d3UgsVfmZloThgvY6mzLzcUDJNT9bS1G7w-VJgzINMbgHqxx7M6bmLJM6zWFxbghICVIuQkk0mEKVuqPDyBtZ1xmnts8AjQ7TP-FIwtmdcMaBY20ZK01VX5_ZkcKfENE-x_zDW_rfkb1JT6GaQHwR7pRI2\" target=\"_blank\">Clinical Quality<\/a>.<\/p>\n<p>Investor Relations:<\/p>\n<p>Ryan Schmidt<\/p>\n<p><a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=VvtjYjO8cOy_mdUUB6S2eb5F9TwHKObCE9isVaEcMV31qRnpKBNRtpL9kGzrhFQELhBTnrTmoVLdm1UX_z6uSTEjNjkdP4MfqFvO_psq2l6vcEEFFAyBzfQ7cG7beLYo\" target=\"_blank\">investors@cloverhealth.com<\/a><\/p>\n<p>Press Inquiries:<\/p>\n<p><a rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=bay7mrRDZsk7msS5jI1_PZ7v5EGCiPsdALeg59g2OgaPfw-HlhMO3tfrEokcghvg1T84iAXBjF9c4nUF6GheUpLn7znWzSsNLfudZgShPF8=\" target=\"_blank\">press@cloverhealth.com<\/a><\/p>\n<p> <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2025\/10\/1760465233_877_ti\"\/> <br \/><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2025\/10\/Clover-Health-Investments-Corp.png\" referrerpolicy=\"no-referrer-when-downgrade\"\/>&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n      &#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n  &#13;<br \/>\n&#13;<\/p>\n<p>&#13;<br \/>\n    FAQ  &#13;\n  <\/p>\n<p>&#13;<br \/>\n  &#13;<br \/>\n  &#13;<\/p>\n<p>        What did Counterpart Health announce on Oct 14, 2025 about CLOV?<\/p>\n<p>&#13;<br \/>\n          Counterpart announced its AI HEDIS flywheel again powered top-tier HEDIS results for Clover and is now available to third-party partners.&#13;\n        <\/p>\n<p>    &#13;<br \/>\n  &#13;<\/p>\n<p>        How did Clover (CLOV) rank in HEDIS clinical quality measures in 2025?<\/p>\n<p>&#13;<br \/>\n          Clover was reported as the #1 performing PPO for HEDIS clinical quality measures among plans with over 2,000 members.&#13;\n        <\/p>\n<p>    &#13;<br \/>\n  &#13;<\/p>\n<p>        What components power Counterpart&#8217;s HEDIS flywheel for CLOV?<\/p>\n<p>&#13;<br \/>\n          The flywheel uses CA point-of-care prompts, real-time data ingestion from 100+ sources, NLP\/LLM abstraction, and AI-assisted documentation closure.&#13;\n        <\/p>\n<p>    &#13;<br \/>\n  &#13;<\/p>\n<p>        What investor impact does Counterpart&#8217;s platform availability to partners have for CLOV?<\/p>\n<p>&#13;<br \/>\n          Opening the platform to third parties may expand revenue channels and scale the technology beyond Clover\u2019s internal use.&#13;\n        <\/p>\n<p>    &#13;<br \/>\n  &#13;<\/p>\n<p>        Which quality measures improved for patients seeing CA-powered providers?<\/p>\n<p>&#13;<br \/>\n          Counterpart cites higher benchmark rates for colorectal cancer screening, breast cancer screening, and diabetic eye exams.&#13;\n        <\/p>\n<p>    &#13;<br \/>\n  &#13;<\/p>\n<p>        How does Counterpart collect patient data for CLOV&#8217;s HEDIS work?<\/p>\n<p>&#13;<br \/>\n          Each CA visit triggers real-time aggregation from more than 100 data sources to build a unified patient view for abstraction and care gaps.&#13;\n        <\/p>\n<p>    &#13;<br \/>\n  &#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n&#13;<\/p>\n","protected":false},"excerpt":{"rendered":"&#13; &#13; &#13; &#13; &#13; &#13; &#13; &#13; Counterpart Health (CLOV) said its AI-driven HEDIS flywheel again powered&hellip;\n","protected":false},"author":2,"featured_media":224577,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[126129,126127,126128,126126,97,252,253],"class_list":["post-224576","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-clov-latest-news","tag-clov-news","tag-clov-stock","tag-clov-stock-news","tag-health","tag-health-care","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/224576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=224576"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/224576\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/224577"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=224576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=224576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=224576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}